Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 Aug;84(2):208–209. doi: 10.1136/heart.84.2.208

Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events

C EREM, T USLU, O DEGER, M TOSUN, H KAVGACI, G BAXTER
PMCID: PMC1760901  PMID: 10908264

Full Text

The Full Text of this article is available as a PDF (598.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Celentano A., Vaccaro O., Tammaro P., Galderisi M., Crivaro M., Oliviero M., Imperatore G., Palmieri V., Iovino V., Riccardi G. Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol. 1995 Dec 1;76(16):1173–1176. doi: 10.1016/s0002-9149(99)80330-0. [DOI] [PubMed] [Google Scholar]
  2. Corrado D., Basso C., Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart. 2000 May;83(5):588–595. doi: 10.1136/heart.83.5.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Erem C., Değer O., Bostan M., Orem A., Sönmez M., Ulusoy S., Telatar M. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiol. 1999 Aug;54(4):203–207. [PubMed] [Google Scholar]
  4. Figueras J., Cortadellas J., Soler-Soler J. Left ventricular free wall rupture: clinical presentation and management. Heart. 2000 May;83(5):499–504. doi: 10.1136/heart.83.5.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kabbaj N., Benjelloun G., Gueddari F. Z., Dafiri R., Imani F. Les atteintes vasculaires de la maladie de Behçet. A propos de 40 dossiers. J Radiol. 1993 Dec;74(12):649–656. [PubMed] [Google Scholar]
  6. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992 Nov;41(11):1422–1428. doi: 10.2337/diab.41.11.1422. [DOI] [PubMed] [Google Scholar]
  7. McMurray J. J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000 May;83(5):596–602. doi: 10.1136/heart.83.5.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000 Feb 29;101(8):899–907. doi: 10.1161/01.cir.101.8.899. [DOI] [PubMed] [Google Scholar]
  9. Nolan J. J., Ludvik B., Beerdsen P., Joyce M., Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994 Nov 3;331(18):1188–1193. doi: 10.1056/NEJM199411033311803. [DOI] [PubMed] [Google Scholar]
  10. Orem A., Değer O., Cimşit G., Karahan S. C., Akyol N., Yildirmiş S. Plasma Lipoprotein(a) and its relationship with disease activity in patients with Behçet's disease. Eur J Clin Chem Clin Biochem. 1995 Aug;33(8):473–478. doi: 10.1515/cclm.1995.33.8.473. [DOI] [PubMed] [Google Scholar]
  11. Regan T. J., Weisse A. B. Diabetic cardiomyopathy. J Am Coll Cardiol. 1992 May;19(6):1165–1166. doi: 10.1016/0735-1097(92)90318-h. [DOI] [PubMed] [Google Scholar]
  12. Scanu A. M., Lawn R. M., Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med. 1991 Aug 1;115(3):209–218. doi: 10.7326/0003-4819-115-3-209. [DOI] [PubMed] [Google Scholar]
  13. Scott J. Lipoprotein(a). Thrombogenesis linked to atherogenesis at last? Nature. 1989 Sep 7;341(6237):22–23. doi: 10.1038/341022a0. [DOI] [PubMed] [Google Scholar]
  14. Williams S. G., Wright D. J., Tan L. B. Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice. Heart. 2000 Jun;83(6):621–626. doi: 10.1136/heart.83.6.621. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES